Panel to Review Drug for Low Female Sex Drive
Article Abstract:
Procter and Gamble may encounter resistance from the Food and Drug Administration in its attempt to license Intrinsa, a female sexual impotence therapy, because clinical trials do not indicate that there is a dramatic difference between the drug and a placebo.
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
A New Trial of Celebrex, and Questions on Its Timing
Article Abstract:
Pfizer's recent announcement that its anti-arthritis medication Bextra increases the risk of heart attack and stroke raises questions about the ethics of its plan to test Celebrex, which is in the same class as Bextra, on human subjects.
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2004
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Setback for Prosecutors in Martha Stewart Trial. Divorced Parents Move, and Custody Gets Trickier
- Abstracts: Making Drugs, Shaping the Rules. New Scrutiny of Drugs in Vioxx's Family. How to Make Pain Relief Cool: Add Ski Bunnies and Mint Flavor
- Abstracts: Delta to Close Song, Its Low-Fare Airline. A Bad August Worsens Airline Financial Woes
- Abstracts: Diet Pill Was a Driving Force in a French Drug Merger. Dollar's Fall Drains Profit of European Small Business
- Abstracts: Convention Visitors to See More Than Just the Garden. Anarchists Emerge as the Convention's Wild Card